Rongkun Li

1.1k total citations
25 papers, 589 citations indexed

About

Rongkun Li is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Rongkun Li has authored 25 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Rongkun Li's work include Microbial metabolism and enzyme function (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Rongkun Li is often cited by papers focused on Microbial metabolism and enzyme function (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Rongkun Li collaborates with scholars based in China, Romania and United States. Rongkun Li's co-authors include Shu‐Heng Jiang, Zhigang Zhang, Xiaomei Yang, Fang Fang, Xiaoxin Zhang, Yahui Wang, Mingyi Shang, Mingxuan Feng, Jun Li and Jun Ma and has published in prestigious journals such as Scientific Reports, Cell stem cell and Frontiers in Immunology.

In The Last Decade

Rongkun Li

24 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rongkun Li China 15 420 260 111 99 99 25 589
Meng-Xuan Zhu China 10 398 0.9× 235 0.9× 156 1.4× 83 0.8× 128 1.3× 15 582
Zhuqing Zhou China 14 329 0.8× 205 0.8× 150 1.4× 97 1.0× 66 0.7× 26 529
Erjie Xia China 17 565 1.3× 423 1.6× 134 1.2× 136 1.4× 70 0.7× 52 789
Kang‐Lai Wei China 13 441 1.1× 325 1.3× 202 1.8× 148 1.5× 64 0.6× 27 680
Bo Ni China 12 282 0.7× 218 0.8× 128 1.2× 116 1.2× 163 1.6× 30 560
Guang-Ang Tian China 13 324 0.8× 180 0.7× 166 1.5× 93 0.9× 129 1.3× 20 582
Junwei Song China 14 547 1.3× 287 1.1× 137 1.2× 81 0.8× 74 0.7× 18 712
Juanni Li China 16 605 1.4× 405 1.6× 112 1.0× 141 1.4× 76 0.8× 39 814
Weihua Li China 16 450 1.1× 434 1.7× 93 0.8× 68 0.7× 102 1.0× 20 670

Countries citing papers authored by Rongkun Li

Since Specialization
Citations

This map shows the geographic impact of Rongkun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongkun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongkun Li more than expected).

Fields of papers citing papers by Rongkun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongkun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongkun Li. The network helps show where Rongkun Li may publish in the future.

Co-authorship network of co-authors of Rongkun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Rongkun Li. A scholar is included among the top collaborators of Rongkun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongkun Li. Rongkun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Rongkun, Xiaojie Wang, Zhiyong Liu, et al.. (2025). Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic kidney disease. Cell stem cell. 32(9). 1390–1402.e9. 2 indexed citations
2.
Li, Rongkun, et al.. (2025). Variable-stiffness mechanism investigation and optimization of SMA hybrid fabric composite leaf springs via an improved genetic algorithm. Materials Today Communications. 46. 112873–112873. 1 indexed citations
3.
Song, Peng, Tongtong Liu, Tingting Shao, et al.. (2025). Traditional Chinese medicine in the treatment of breast Cancer. Molecular Cancer. 24(1). 209–209.
4.
Xiao, Xi, Caifeng Zou, Yishen Mao, et al.. (2024). Ubiquitin-specific protease 7 maintains c-Myc stability to support pancreatic cancer glycolysis and tumor growth. Journal of Translational Medicine. 22(1). 1135–1135. 9 indexed citations
5.
Zhu, Lili, Botai Li, Rongkun Li, et al.. (2023). METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity. Cellular Oncology. 46(5). 1529–1541. 6 indexed citations
6.
Chen, Fei, Chuansheng Chen, Kai‐Jun Zhang, et al.. (2022). CXCR2 Is Essential for Radiation-Induced Intestinal Injury by Initiating Neutrophil Infiltration. Journal of Immunology Research. 2022. 1–9. 10 indexed citations
7.
Yu, Minhao, Hao Wang, Wei Zhao, et al.. (2022). Targeting type Iγ phosphatidylinositol phosphate kinase overcomes oxaliplatin resistance in colorectal cancer. Theranostics. 12(9). 4386–4398. 14 indexed citations
8.
Huang, Wei, Yunfeng Hou, Yi Fu, et al.. (2022). JAML promotes acute kidney injury mainly through a macrophage-dependent mechanism. JCI Insight. 7(14). 40 indexed citations
9.
Li, Rongkun, Lili Zhu, Xiaoxin Zhang, et al.. (2021). Reciprocal regulation of LOXL2 and HIF1α drives the Warburg effect to support pancreatic cancer aggressiveness. Cell Death and Disease. 12(12). 1106–1106. 27 indexed citations
11.
Wang, Xu, Xiao Yuan, Jing Hu, et al.. (2021). Targeting Purinergic Receptor P2RX1 Modulates Intestinal Microbiota and Alleviates Inflammation in Colitis. Frontiers in Immunology. 12. 696766–696766. 17 indexed citations
12.
Dong, Fangyuan, Rongkun Li, Jiaofeng Wang, et al.. (2021). Hypoxia-dependent expression of MAP17 coordinates the Warburg effect to tumor growth in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 40(1). 121–121. 14 indexed citations
13.
Zhu, Lili, Zheng Wu, Rongkun Li, et al.. (2020). Deciphering the genomic and lncRNA landscapes of aerobic glycolysis identifies potential therapeutic targets in pancreatic cancer. International Journal of Biological Sciences. 17(1). 107–118. 24 indexed citations
14.
Zhang, Xiao-Xin, Bo Ni, Qing Li, et al.. (2019). GPAA1 promotes gastric cancer progression via upregulation of GPI-anchored protein and enhancement of ERBB signalling pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 214–214. 17 indexed citations
15.
Li, Rongkun, Li Weng, Bingyan Liu, et al.. (2019). TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR‐glycolysis signaling axis. Journal of Cellular Biochemistry. 121(2). 1986–1997. 24 indexed citations
16.
Wang, Yahui, Rongkun Li, Ying Fu, et al.. (2017). Exemestane Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells and Promoting the Secretion of Interleukin 10. Journal of Immunology Research. 2017. 1–9. 6 indexed citations
17.
Li, Rongkun, Chun Zhuang, Shu‐Heng Jiang, et al.. (2017). ITGBL1 Predicts a Poor Prognosis and Correlates EMT Phenotype in Gastric Cancer. Journal of Cancer. 8(18). 3764–3773. 24 indexed citations
18.
Tian, Guang-Ang, Chunchao Zhu, Xiao-Xin Zhang, et al.. (2016). CCBE1 promotes GIST development through enhancing angiogenesis and mediating resistance to imatinib. Scientific Reports. 6(1). 31071–31071. 25 indexed citations
19.
Li, Rongkun, Wenyi Zhao, Fang Fang, et al.. (2014). Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway. Journal of Cancer Research and Clinical Oncology. 141(2). 269–281. 56 indexed citations
20.
He, Ping, Shu-Heng Jiang, Mingze Ma, et al.. (2012). Trophoblast glycoprotein promotes pancreatic ductal adenocarcinoma cell metastasis through Wnt/planar cell polarity signaling. Molecular Medicine Reports. 12(1). 503–509. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026